These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 20861192

  • 1. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F, Zhang L, O'Toole SA, Browne BC, Pinese M, Porta Cubas A, Lehrbach GM, Croucher DR, Rickwood D, Boulghourjian A, Shearer R, Nair R, Swarbrick A, Faratian D, Mullen P, Harrison DJ, Biankin AV, Sutherland RL, Raftery MJ, Daly RJ.
    Cancer Res; 2010 Nov 15; 70(22):9391-401. PubMed ID: 20861192
    [Abstract] [Full Text] [Related]

  • 2. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM, Virnig C, Cance WG.
    Mol Carcinog; 2008 Mar 15; 47(3):222-34. PubMed ID: 17849451
    [Abstract] [Full Text] [Related]

  • 3. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
    Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE.
    J Cell Biochem; 2009 Aug 15; 107(6):1168-81. PubMed ID: 19533669
    [Abstract] [Full Text] [Related]

  • 4. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL, Tong J, Taylor P, St-Germain JR, Navab R, Moran MF, Tsao MS.
    J Proteome Res; 2011 Jul 01; 10(7):3200-11. PubMed ID: 21609022
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Src impairs the growth of met-addicted gastric tumors.
    Bertotti A, Bracco C, Girolami F, Torti D, Gastaldi S, Galimi F, Medico E, Elvin P, Comoglio PM, Trusolino L.
    Clin Cancer Res; 2010 Aug 01; 16(15):3933-43. PubMed ID: 20628031
    [Abstract] [Full Text] [Related]

  • 6. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
    Yamamoto N, Mammadova G, Song RX, Fukami Y, Sato K.
    J Cell Sci; 2006 Nov 15; 119(Pt 22):4623-33. PubMed ID: 17062641
    [Abstract] [Full Text] [Related]

  • 7. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE.
    Cancer Res; 2010 May 15; 70(10):4151-62. PubMed ID: 20460524
    [Abstract] [Full Text] [Related]

  • 8. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S, Sassi F, Accornero P, Torti D, Galimi F, Migliardi G, Molyneux G, Perera T, Comoglio PM, Boccaccio C, Smalley MJ, Bertotti A, Trusolino L.
    Oncogene; 2013 Mar 14; 32(11):1428-40. PubMed ID: 22562252
    [Abstract] [Full Text] [Related]

  • 9. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
    Kim YJ, Choi JS, Seo J, Song JY, Lee SE, Kwon MJ, Kwon MJ, Kundu J, Jung K, Oh E, Shin YK, Choi YL.
    Int J Cancer; 2014 May 15; 134(10):2424-36. PubMed ID: 24615768
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
    Leung EL, Wong JC, Johlfs MG, Tsang BK, Fiscus RR.
    Mol Cancer Res; 2010 Apr 15; 8(4):578-91. PubMed ID: 20371672
    [Abstract] [Full Text] [Related]

  • 11. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, de Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F.
    Cancer Res; 2005 Nov 15; 65(22):10585-93. PubMed ID: 16288052
    [Abstract] [Full Text] [Related]

  • 12. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 13. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN, Graham JD, Bouton AH, Clarke CL, O'Neill GM.
    Oncogene; 2006 Dec 07; 25(58):7597-607. PubMed ID: 16799644
    [Abstract] [Full Text] [Related]

  • 14. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
    Fu XD, Goglia L, Sanchez AM, Flamini M, Giretti MS, Tosi V, Genazzani AR, Simoncini T.
    Endocr Relat Cancer; 2010 Jun 07; 17(2):431-43. PubMed ID: 20233709
    [Abstract] [Full Text] [Related]

  • 15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC, Hochgräfe F, Wu J, Millar EK, Barraclough J, Stone A, McCloy RA, Lee CS, Roberts C, Ali NA, Boulghourjian A, Schmich F, Linding R, Farrow L, Gee JM, Nicholson RI, O'Toole SA, Sutherland RL, Musgrove EA, Butt AJ, Daly RJ.
    FEBS J; 2013 Nov 07; 280(21):5237-57. PubMed ID: 23876235
    [Abstract] [Full Text] [Related]

  • 16. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H, Washington S, Verderame MF, Manni A.
    Breast Cancer Res Treat; 2008 Nov 07; 112(2):255-61. PubMed ID: 18097746
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 07; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 18. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
    Hiscox S, Morgan L, Green TP, Barrow D, Gee J, Nicholson RI.
    Breast Cancer Res Treat; 2006 Jun 07; 97(3):263-74. PubMed ID: 16333527
    [Abstract] [Full Text] [Related]

  • 19. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH, O'Kelly J, Lu D, Iwanski GB, La DT, Abbassi S, Leiter A, Karlan B, Mehta R, Koeffler HP.
    Oncogene; 2010 Jan 14; 29(2):285-96. PubMed ID: 19855437
    [Abstract] [Full Text] [Related]

  • 20. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
    Zrihan-Licht S, Fu Y, Settleman J, Schinkmann K, Shaw L, Keydar I, Avraham S, Avraham H.
    Oncogene; 2000 Mar 02; 19(10):1318-28. PubMed ID: 10713673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.